COCH ENVOY MEDICAL INC revenue, earnings and financials
For the quarter ended June 30, 2026, ENVOY MEDICAL INC reported revenue of $51.0K (down 34.6% from a year earlier), net income of −$5.98M and diluted EPS of −$0.07; over the last four quarters revenue was $207K and net income −$23.4M; for the fiscal year ended December 2025 revenue was $241K, up 7.1% on the year before.
COCH annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $241K, gross profit n/a, operating income −$22.3M, net income −$23.8M (margin -9857.3%), EPS −$1.23
- Fiscal year ended Dec 2024: revenue $225K, gross profit n/a, operating income −$19.3M, net income −$20.8M (margin -9242.2%), EPS −$1.49
- Fiscal year ended Dec 2023: revenue $316K, gross profit n/a, operating income −$18.4M, net income −$29.9M (margin -9469.0%), EPS −$2.54
- Fiscal year ended Dec 2022: revenue $237K, gross profit n/a, operating income −$8.71M, net income −$15.9M (margin -6718.6%), EPS −$1.57
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$5.20M, net income −$252K (margin n/a), EPS n/a
COCH quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $51.0K (down 34.6% year over year), net income −$5.98M, EPS −$0.07
- Quarter ended Mar 31, 2026: revenue $39.0K (down 15.2% year over year), net income −$4.35M, EPS −$0.08
- Quarter ended Dec 31, 2025 (from the annual report): revenue $75.0K (up 78.6% year over year), net income −$6.59M, EPS −$0.27
- Quarter ended Sep 30, 2025: revenue $42.0K (down 25.0% year over year), net income −$6.48M, EPS −$0.35
- Quarter ended Jun 30, 2025: revenue $78.0K (up 14.7% year over year), net income −$5.69M, EPS −$0.32
- Quarter ended Mar 31, 2025: revenue $46.0K (down 22.0% year over year), net income −$5.00M, EPS −$0.29
- Quarter ended Dec 31, 2024 (from the annual report): revenue $42.0K (down 55.8% year over year), net income −$4.62M, EPS −$0.40
- Quarter ended Sep 30, 2024: revenue $56.0K (down 30.0% year over year), net income −$5.96M, EPS −$0.39
- Quarter ended Jun 30, 2024: revenue $68.0K (up 7.9% year over year), net income −$3.95M, EPS −$0.29
- Quarter ended Mar 31, 2024: revenue $59.0K (down 24.4% year over year), net income −$6.27M, EPS −$0.41
- Quarter ended Dec 31, 2023 (from the annual report): revenue $95.0K, net income −$4.90M, EPS −$0.05
- Quarter ended Sep 30, 2023: revenue $80.0K (up 40.4% year over year), net income $1.56M, EPS $0.13
- Quarter ended Jun 30, 2023: revenue $63.0K, net income −$13.3M, EPS −$1.31
- Quarter ended Mar 31, 2023: revenue $78.0K, net income −$13.3M, EPS −$1.31
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$11.5M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $57.0K, net income −$1.34M, EPS −$0.13
- Quarter ended Jun 30, 2022: revenue n/a, net income −$1.24M, EPS n/a
- Quarter ended Mar 31, 2022: revenue n/a, net income −$1.87M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$4.72M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income $5.57M, EPS n/a
COCH cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$18.2M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$17.9M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$17.1M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$8.81M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$3.24M, share buybacks n/a
COCH balance sheet
- Jun 30, 2026: cash n/a, total assets $23.9M, total liabilities $20.3M, shareholders' equity $3.30M
- Mar 31, 2026: cash n/a, total assets $29.8M, total liabilities $19.3M, shareholders' equity $10.2M
- Dec 31, 2025: cash n/a, total assets $8.56M, total liabilities $20.3M, shareholders' equity −$12.2M
- Sep 30, 2025: cash n/a, total assets $8.18M, total liabilities $15.7M, shareholders' equity −$7.66M
- Jun 30, 2025: cash n/a, total assets $9.90M, total liabilities $39.8M, shareholders' equity −$29.9M
- Mar 31, 2025: cash n/a, total assets $10.4M, total liabilities $34.6M, shareholders' equity −$24.2M
- Dec 31, 2024: cash n/a, total assets $11.5M, total liabilities $30.4M, shareholders' equity −$18.8M
- Sep 30, 2024: cash n/a, total assets $9.40M, total liabilities $27.9M, shareholders' equity −$18.5M
What is COCH's revenue?
ENVOY MEDICAL INC reported $207K of revenue over its last four quarters, through June 30, 2026.
Is COCH profitable?
No. ENVOY MEDICAL INC lost $23.4M over the last four quarters.
What is COCH's EPS?
Diluted earnings per share over the last four quarters were −$0.77; −$0.07 in the latest quarter.